€ 20,70
WARNINGS
To achieve effective parasite control, treatment should be based on the results of the parasitological examination of feces. It is not necessary to fast the animal during treatment; however, it is good practice to provide the animal with lighter and reduced meals starting from the day before deworming. It is preferable to administer the drug on an empty stomach. From the first administration, the elimination of parasites begins, and the disappearance of eggs usually occurs within 10 – 15 days after the last administration. Therefore, the fecal examination for control should be performed after the aforementioned period. During treatment and even afterward, it is necessary to carry out appropriate disinfestation operations in kennels or breeding facilities to avoid reinfestations. Furthermore, it is advisable to chemically denature the feces expelled by treated subjects to destroy any live parasites emitted and thus interrupt the continuation of the parasitic cycle. Special precautions for use in animals: none. Special precautions to be taken by the person administering the product to animals: none. Administration of excessive doses does not cause any symptoms other than vomiting above 500 mg/Kg of active ingredient in dogs and 300 mg/Kg of active ingredient in cats. In the absence of compatibility studies, do not mix with other medicines.
PHARMACOTHERAPEUTIC CATEGORY
Multivalent anthelmintic based on Mebendazole.
STORAGE
Store at room temperature. Keep the bottle tightly closed. Keep out of reach of children. Shelf life of the veterinary medicine packaged for sale: 4 years.
CONTRAINDICATIONS/ADVERSE EFFECTS
None.
NAME
LENDUE DROPS 120 MG/G ORAL SUSPENSION FOR DOGS AND CATS
DIAGNOSIS AND PRESCRIPTION
Veterinary medicine without a veterinary prescription requirement.
EXCIPIENTS
White petrolatum, olive oil.
ADVERSE EFFECTS
Report any serious adverse reactions and/or reactions not mentioned in this SPC.
PREGNANCY AND LACTATION
Do not administer Lendue drops in the first fifteen days of pregnancy. In the absence of studies on the target species, administer in the remaining 45 days of pregnancy and during lactation only in accordance with the risk/benefit assessment of the responsible veterinarian.
INDICATIONS
Parasitic infestations caused by: Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp.
INTERACTIONS
None known.
DOSAGE
For oral use. One drop of suspension contains 3.75 mg of active substance. Administer 8 drops per kg of animal weight per day (equivalent to 30 mg/Kg body weight/day of Mebendazole): for two consecutive days, in infestations caused by Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp., whether single or mixed; for one day only, in infestations caused solely by blood-feeding worms Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala. Lendue drops can be administered to puppies even in the first weeks of life without any inconvenience. Always round the weight of the animal to the next whole number. The drops are palatable to animals; they can be administered directly into the mouth or mixed with palatable food. Shake very vigorously before use, until complete redispersion of the sediment. With the administration of Lendue drops according to the indicated methods, total disappearance of adult parasites is achieved; to eliminate larval forms, it is necessary to repeat the complete treatment after 60 days for Ascarid infestations and after 18 days for Ancylostoma infestations from the end of the first treatment.
ACTIVE INGREDIENTS
100 g of suspension contain: active ingredient: micronized mebendazole 12 g. For the complete list of excipients, see * 6.1.
SAFETY IN TARGET SPECIES
Administration of excessive doses does not cause any symptoms other than vomiting above 500 mg/Kg of active ingredient in dogs and 300 mg/Kg of active ingredient in cats.
TARGET SPECIES
Dogs and cats.
WITHDRAWAL TIME
Not relevant.
ADMINISTRATION/ROUTE OF ADMINISTRATION
For oral use.
€ 20,70
WARNINGS
To achieve effective parasite control, treatment should be based on the results of the parasitological examination of feces. It is not necessary to fast the animal during treatment; however, it is good practice to provide the animal with lighter and reduced meals starting from the day before deworming. It is preferable to administer the drug on an empty stomach. From the first administration, the elimination of parasites begins, and the disappearance of eggs usually occurs within 10 – 15 days after the last administration. Therefore, the fecal examination for control should be performed after the aforementioned period. During treatment and even afterward, it is necessary to carry out appropriate disinfestation operations in kennels or breeding facilities to avoid reinfestations. Furthermore, it is advisable to chemically denature the feces expelled by treated subjects to destroy any live parasites emitted and thus interrupt the continuation of the parasitic cycle. Special precautions for use in animals: none. Special precautions to be taken by the person administering the product to animals: none. Administration of excessive doses does not cause any symptoms other than vomiting above 500 mg/Kg of active ingredient in dogs and 300 mg/Kg of active ingredient in cats. In the absence of compatibility studies, do not mix with other medicines.
PHARMACOTHERAPEUTIC CATEGORY
Multivalent anthelmintic based on Mebendazole.
STORAGE
Store at room temperature. Keep the bottle tightly closed. Keep out of reach of children. Shelf life of the veterinary medicine packaged for sale: 4 years.
CONTRAINDICATIONS/ADVERSE EFFECTS
None.
NAME
LENDUE DROPS 120 MG/G ORAL SUSPENSION FOR DOGS AND CATS
DIAGNOSIS AND PRESCRIPTION
Veterinary medicine without a veterinary prescription requirement.
EXCIPIENTS
White petrolatum, olive oil.
ADVERSE EFFECTS
Report any serious adverse reactions and/or reactions not mentioned in this SPC.
PREGNANCY AND LACTATION
Do not administer Lendue drops in the first fifteen days of pregnancy. In the absence of studies on the target species, administer in the remaining 45 days of pregnancy and during lactation only in accordance with the risk/benefit assessment of the responsible veterinarian.
INDICATIONS
Parasitic infestations caused by: Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp.
INTERACTIONS
None known.
DOSAGE
For oral use. One drop of suspension contains 3.75 mg of active substance. Administer 8 drops per kg of animal weight per day (equivalent to 30 mg/Kg body weight/day of Mebendazole): for two consecutive days, in infestations caused by Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp., whether single or mixed; for one day only, in infestations caused solely by blood-feeding worms Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala. Lendue drops can be administered to puppies even in the first weeks of life without any inconvenience. Always round the weight of the animal to the next whole number. The drops are palatable to animals; they can be administered directly into the mouth or mixed with palatable food. Shake very vigorously before use, until complete redispersion of the sediment. With the administration of Lendue drops according to the indicated methods, total disappearance of adult parasites is achieved; to eliminate larval forms, it is necessary to repeat the complete treatment after 60 days for Ascarid infestations and after 18 days for Ancylostoma infestations from the end of the first treatment.
ACTIVE INGREDIENTS
100 g of suspension contain: active ingredient: micronized mebendazole 12 g. For the complete list of excipients, see * 6.1.
SAFETY IN TARGET SPECIES
Administration of excessive doses does not cause any symptoms other than vomiting above 500 mg/Kg of active ingredient in dogs and 300 mg/Kg of active ingredient in cats.
TARGET SPECIES
Dogs and cats.
WITHDRAWAL TIME
Not relevant.
ADMINISTRATION/ROUTE OF ADMINISTRATION
For oral use.
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.

You need to be logged in to use the wishlist ❤️
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.